Publications dans lesquelles il/elle collabore avec Jesús María Hernández Rivas (32)

2024

  1. Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis

    American Journal of Hematology

2023

  1. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  2. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

  3. Implementación de flipped learning y evaluación entre iguales en la enseñanza de la genética clínica mediante las redes sociales

    Proceedings 2nd international congress: education and knowledge

2022

  1. Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools

    Value in Health, Vol. 25, Núm. 10, pp. 1760-1767

  2. TRAF3 alterations are frequent in del-3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features

    American Journal of Hematology, Vol. 97, Núm. 7, pp. 903-914

  3. Uso de las redes sociales Twitter e Instagram como herramientas docentes para la enseñanza de la genética clínica en la Universidad de Salamanca

    La necesidad de la transformación social desde la innovación docente y educativa (Aula Magna), pp. 261-279

  4. Uso de las redes sociales de Twitter e Instagram como herramientas docentes para la enseñanza de la genética clínica en la Universidad de Salamanca

    Educación y transferencia del conocimiento: propuesta de innovación para la mejora docente

  5. Uso de las redes sociales de Twitter e Instagram como herramientas docentes para la enseñanza de la genética clínica en la Universidad de Salamanca

    Educación y transferencia del conocimiento: propuestas de innovación para la mejora docente. Libro de resúmenes del I Congreso Internacional Docente, Educación y Transferencia del Conocimiento

2021

  1. Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression

    Blood Cancer Journal, Vol. 11, Núm. 7

  2. NEMHESYS - European Perspective on the Implementation of Next-generation Sequencing Into Clinical Diagnostics

    HemaSphere, Vol. 5, Núm. 3, pp. E541

  3. The evolving landscape of chronic lymphocytic leukemia on diagnosis, prognosis and treatment

    Diagnostics, Vol. 11, Núm. 5

2020

  1. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

  2. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications

    International Journal of Cancer, Vol. 147, Núm. 10, pp. 2780-2792

  3. Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients

    Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 664-671

  4. Transcriptomic analysis of patients with immune thrombocytopenia treated with eltrombopag

    Platelets, Vol. 31, Núm. 8, pp. 993-1000

2019

  1. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase

    Leukemia, Vol. 33, Núm. 2, pp. 518-558

  2. DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains

    Experimental Hematology, Vol. 72, pp. 9-13

2018

  1. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia

    Leukemia and Lymphoma, Vol. 59, Núm. 3, pp. 633-642

  2. The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers only Prognostic Model and the MD Anderson Cancer Center Prognostic Index

    BioMed Research International, Vol. 2018